Conditions That Mimic Cerebral Palsy: Differential Diagnosis Parents Should Know

Most children diagnosed with cerebral palsy do have cerebral palsy. But not all do. Several conditions can present with motor symptoms similar to CP but have different underlying causes, some of which are treatable. For families whose child has been given a CP diagnosis but whose course or workup raises questions, understanding the differential diagnosis is essential. This guide walks through the major CP mimics organized by category, the red flags that should prompt further evaluation, and the treatable conditions that should never be missed.

Why a Differential Diagnosis Matters

The 2004 American Academy of Neurology Practice Parameter on CP diagnostic assessment (Ashwal et al., Neurology) emphasized that comprehensive evaluation is part of standard CP care, not just label confirmation. Studies suggest that 5 to 15 percent of children initially diagnosed with CP have an alternative or contributing diagnosis when thorough workup is performed. The proportion is higher when:

• No clear perinatal cause was documented.
• Brain MRI is normal or shows atypical findings.
• Symptoms appear to be progressing rather than stable.
• The child has lost previously acquired skills.
• There is a family history of similar conditions.
• Associated features outside the brain are present (cardiac, hepatic, ocular).

The most clinically important reason to maintain a differential is that some mimics are treatable, and identification can transform a child’s trajectory.

The Single Most Important Red Flag: Progression

Cerebral palsy is, by definition, a non-progressive motor disorder. The underlying brain injury is not getting worse over time. Functional difficulties may become more apparent as the child grows and tries new motor tasks (a child whose CP looked mild at 12 months may have visible difficulty at 4 years when expected to write or run), but the injury itself is stable.

If a child’s motor symptoms are clearly worsening, or if they lose previously acquired skills, the diagnosis is unlikely to be pure CP. Progressive features should prompt evaluation for:

• Genetic neurodegenerative conditions.
• Metabolic disorders with intermittent or progressive courses.
• Hereditary spastic paraplegia.
• Mitochondrial conditions.
• Spinal cord conditions.
• Other progressive disorders.

Treatable Mimics That Should Never Be Missed

A small but critically important group of CP mimics has specific, effective treatments:

Dopa-responsive dystonia in detail

Dopa-responsive dystonia (DRD) deserves particular attention because it is sometimes mistaken for CP and responds dramatically to treatment. DRD is caused by mutations in genes affecting dopamine synthesis (most commonly GCH1). Children typically present in the first decade with progressive lower-extremity dystonia or spasticity. The hallmark feature is diurnal variation: symptoms are worse in the evening and after exertion, and improve after sleep. Some children have been diagnosed with spastic CP and walked with progressive difficulty for years before a pediatric neurologist suggested an L-DOPA trial. The response to low-dose L-DOPA is often immediate and complete. A reasonable rule: any child with apparent dystonia or spasticity that varies through the day, or whose course doesn’t fit pure CP, should have an L-DOPA trial considered.

Other Major Mimics by Category

Neuromuscular conditions

Spinal muscular atrophy (SMA) is the most important neuromuscular CP mimic. SMA presents with hypotonia and weakness, and is distinguished from CP by peripheral findings (diminished or absent reflexes, fasciculations of the tongue, electrically silent muscles). SMA is now on most state newborn screening panels, but earlier or untreated cases can be misdiagnosed. Disease-modifying therapies (nusinersen, onasemnogene abeparvovec gene therapy, risdiplam) have transformed SMA outcomes when started early.

Congenital muscular dystrophies can produce hypotonia and weakness in infancy that may be confused with CP. Specific muscular dystrophies have specific genetic and clinical features.

Charcot-Marie-Tooth disease and other hereditary peripheral neuropathies can produce gait abnormalities in older children that may be misattributed to CP.

Genetic neurodegenerative conditions

Several genetic conditions cause progressive neurological dysfunction that may initially look like CP. These include lysosomal storage diseases, leukodystrophies, neuronal ceroid lipofuscinoses, mitochondrial disorders, and a growing list of others. Progressive features, regression, and abnormal MRI patterns are common red flags.

Hereditary spastic paraplegia

Hereditary spastic paraplegia (HSP) is a group of genetic conditions causing progressive lower-extremity spasticity. In children, HSP can be mistaken for spastic diplegic CP. Distinguishing features: progressive course (worsening over years), often family history (though new mutations occur), and characteristic MRI findings in some forms. Genetic testing for HSP genes (SPG genes, ATL1, KIF1A, and others) can confirm the diagnosis.

Inborn errors of metabolism

Several metabolic conditions can present with CP-like features:

• Glutaric aciduria type I: can cause severe basal ganglia injury during metabolic crises, mimicking dyskinetic CP. Often on newborn screening but presents acutely.
• Methylmalonic and propionic acidemias: can produce extrapyramidal features.
• Mitochondrial disorders: diverse presentations including CP-like features.
• Phenylketonuria (untreated or late-diagnosed): rare in screened populations.
• Lesch-Nyhan syndrome: dyskinetic features plus self-injurious behavior.

Structural conditions

Tethered cord syndrome can present with progressive leg weakness, gait changes, and bladder dysfunction that may be misdiagnosed as spastic CP. Skin abnormalities over the lower spine (dimples, hair tufts, hemangiomas) can be clues. Spinal MRI confirms diagnosis. Surgical untethering is the treatment.

Chiari malformations and other posterior fossa anomalies can produce ataxia, weakness, and other features that may overlap with CP.

What a Comprehensive Workup Includes

The 2004 AAN Practice Parameter and subsequent guidance recommend several elements:

Why this matters even when the diagnosis seems clear

Even when CP is clinically obvious and a clear perinatal cause is documented, a thorough workup helps confirm the diagnosis and rule out coexisting conditions. Some children have both birth-injury CP and a separate genetic or metabolic condition that affects management. Comprehensive evaluation also documents the diagnostic process for future medical and educational planning, and provides a baseline against which to compare any future changes. The workup does not need to be exhaustive in every case; the depth depends on clinical features, perinatal history, family history, and the questions that remain.

What newborn screening catches and what it misses

State newborn screening programs in the United States typically test for 30 to 60 conditions, depending on the state. Most include several conditions relevant to CP-mimics: biotinidase deficiency, phenylketonuria, certain organic acidemias (including glutaric aciduria type I in many states), spinal muscular atrophy (now in nearly all states), and others. Newborn screening is highly effective when it works: a normal screen significantly reduces but does not eliminate the chance of these specific conditions, since false-negatives can occur and not every condition is on the panel. Conditions not typically on newborn screening include hereditary spastic paraplegia, dopa-responsive dystonia, most lysosomal storage diseases, and most genetic neurodegenerative conditions. If your child’s symptoms developed despite a normal newborn screen, the screen does not rule out other genetic and metabolic conditions; further targeted workup may still be appropriate.

Mimics that warrant case review when missed

From a case-review perspective, the most concerning scenarios are those where a treatable mimic was missed and the child suffered preventable harm. Specific examples worth discussing with a clinical reviewer include: a child with progressive dystonia or spasticity who never had an L-DOPA trial despite features suggesting DRD; a baby with hypotonia and weakness whose newborn SMA screen result was missed or not followed up; a child with biotinidase deficiency whose newborn screen was abnormal but who was not started on biotin promptly; a child with episodic encephalopathy and abnormal labs who was not evaluated for organic acidemia; a child with progressive lower-extremity symptoms and a lumbar skin lesion who did not have spinal MRI for tethered cord. In each of these scenarios, identifying the condition earlier could have changed the trajectory. A case review examines whether the workup was appropriate to the presenting features and whether available diagnostic tests were ordered.

What Parents Should Watch For

Specific features that warrant a conversation with your pediatric neurologist about whether the diagnosis is complete:

• Loss of skills the child previously had.
• Worsening symptoms that are not explained by growth or new motor demands.
• Diurnal variation in symptoms (better in morning, worse in evening, or vice versa).
• Family history of unexplained motor problems, gait disorders, or developmental delay.
• Associated features outside the brain (cardiac murmurs, liver enlargement, eye abnormalities, skin findings).
• Normal brain MRI in a child with significant motor symptoms.
• Episodic worsening with illness or fasting.
• Atypical movement patterns not fitting standard CP subtypes.

Related reading for parents

• Genetic causes of cerebral palsy: when CP isn’t caused by birth injury
• Ataxic cerebral palsy: understanding balance and coordination challenges
• Mixed cerebral palsy: when a child has symptoms of more than one CP type
• MACS, CFCS, and EDACS: the CP classification systems beyond GMFCS
• Neonatal encephalopathy vs HIE: understanding the terminology doctors use